| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 360 | $50 | $18.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 160 | $90 | $14K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 40 | $290 | $12.5K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 80 | $140 | $10.3K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 70 | $120 | $8.2K |
| 93297 | The provider, who is a physician or other qualified healthcare professional, evaluates the physiologic data from the implantable physiologic cardiovascular monitoring system during a period of up 30… | 310 | $20 | $5.5K |
| 93298 | The provider, who is a physician or other qualified healthcare professional, evaluates the data from a previously implanted subcutaneous cardiac rhythm monitor system via telemetric communication for… | 220 | $20 | $4.2K |
| J2785 | Injection, regadenoson, 0.1 mg | 80 | $50 | $3.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 50 | $70 | $3.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $120 | $2.7K |